We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 41-60 of 10,000 results
  1. A nutrient-limited screen unmasks rifabutin hyperactivity for extensively drug-resistant Acinetobacter baumannii

    Industry screens of large chemical libraries have traditionally relied on rich media to ensure rapid bacterial growth in high-throughput testing. We...

    Brian Luna, Vincent Trebosc, ... Brad Spellberg in Nature Microbiology
    Article 08 June 2020
  2. Distribution and Clonality of drug-resistant tuberculosis in South Africa

    Background

    Studies have shown that drug-resistant tuberculosis (DR-TB) in South Africa (SA) is clonal and is caused mostly by transmission....

    Halima Said, John Ratabane, ... Nazir Ismail in BMC Microbiology
    Article Open access 28 May 2021
  3. Complete genome sequence of an extensively drug resistant (XDR) M. morganii SMM01 isolated from a patient with urinary and fecal incontinence

    Objective

    M. morganii is a gram-negative, non-lactose fermenting and an opportunistic pathogen frequently associated with nosocomial infections....

    Pachi Pulusu Chanakya, Balaram Khamari, ... Eswarappa Pradeep Bulagonda in BMC Genomic Data
    Article Open access 16 August 2021
  4. Drug Discovery for Targeting Drug Resistant Bacteria

    The alternative approaches for antibacterial drug discovery have a huge potential to develop novel antibacterial agents against multi drug resistant...
    Aikaterini Valsamatzi-Panagiotou, Katya B. Popova, Robert Penchovsky in Sustainable Agriculture Reviews 46
    Chapter 2020
  5. Multi-drug resistant (MDR), extended spectrum beta-lactamase (ESBL) producing and carbapenem resistant Escherichia coli in rescued Sloth bears (Melursus ursinus), India

    The study reports the multi-drug resistant (MDR), extended spectrum beta-lactamase (ESBL) producing and carbapenem resistant Escherichia coli (CRE)...

    O. R. VinodhKumar, M. Karikalan, ... A. K. Sharma in Veterinary Research Communications
    Article 26 May 2021
  6. Screening, Characterization and Optimization of Bioactive Peptides with Antibacterial Activities Against Multi-Drug Resistant Pathogens, Produced by Bacillus safensis Strain MK-12.1

    Antimicrobial resistance in pathogenic bacteria is increasing rapidly. Therefore, investigation of novel therapeutic agents are essential to combat...

    Sajid Iqbal, Farida Begum, Muhammad Qasim in International Journal of Peptide Research and Therapeutics
    Article 09 November 2022
  7. Investigating Combination Therapy as a Means to Enhance Activity and Repurpose Antimicrobials

    Current clinical practice assumes that a single antibiotic given as a bolus or as a course will successfully treat most infections. In modern...
    Robert J. H. Hammond in Antibiotic Resistance Protocols
    Protocol 2024
  8. In vitro investigation of relationship between quorum-sensing system genes, biofilm forming ability, and drug resistance in clinical isolates of Pseudomonas aeruginosa

    Background

    Pseudomonas aeruginosa is an opportunistic pathogen in the health-care systems and one of the primary causative agents with high mortality...

    Jaber Hemmati, Mohsen Nazari, ... Babak Asghari in BMC Microbiology
    Article Open access 25 March 2024
  9. Association of Mutations in gyrA Gene with Resistance to Fluoroquinolones in Clinical Isolates of Multidrug-Resistant Mycobacterium tuberculosis

    Abstract

    The purpose of the present study was to evaluate the association of mutations inside and outside quinolone-resistance determining region...

    Hanieh Bagherifard, Mitra Salehi, Mona Ghazi in Molecular Genetics, Microbiology and Virology
    Article 01 December 2023
  10. Assessment of the GenoType MTBDRsl VER 2.0 compared to the phenotypic drug susceptibility testing and whole genome sequencing for the rapid detection of resistance to fluoroquinolone and second-line injectable drugs among rifampicin-resistant Mycobacterium tuberculosis isolates

    Molecular techniques have considerable advantages for rapid detection, a reduction of infectiousness, prevention of further resistance development...

    Jalil Kardan-Yamchi, Sirus Amini, ... Mohammad Mehdi Feizabadi in Archives of Microbiology
    Article 25 May 2021
  11. Asiaticoside A for the modulation of 1-TbAd- a potential target and ligand for extensive drug resistance Mycobacterium tuberculosis

    In nature, terpene nucleosides are relatively rare, with 1-tuberculosinyladenosine (1-TbAd) being an exclusive feature of Mycobacterium tuberculosis ...

    Komal Tilwani, Abhishek Patel, ... Gayatri Dave in AMB Express
    Article Open access 13 October 2023
  12. Vanilla modulates the activity of antibiotics and inhibits efflux pumps in drug-resistant Pseudomonas aeruginosa

    Vanilla, a popular flavour extracted from Vanilla planifolia pods was tested for its antibiotic modulatory activity against extensively...

    Sagar S. Arya, Mansi M. Sharma, ... Sangram K. Lenka in Biologia
    Article 04 November 2020
  13. Association of Mutations in gyrA Gene with Resistance to Fluoroquinolones in Clinical Isolates of Multidrug-Resistant Mycobacterium tuberculosis

    Abstract

    The purpose of the present study was to evaluate the association of mutations inside and outside quinolone-resistance determining region...

    Hanieh Bagherifard, Mitra Salehi, Mona Ghazi in Molecular Genetics, Microbiology and Virology
    Article 01 June 2023
  14. Clostridioides difficile and multi-drug-resistant staphylococci in free-living rodents and marsupials in parks of Belo Horizonte, Brazil

    The global emergence of antimicrobial resistance (AMR) has become a serious threat to human and animal health. Recent studies have shown that...

    Jordana Almeida Santana, Salene Angelini Colombo, ... Rodrigo Otávio Silveira Silva in Brazilian Journal of Microbiology
    Article 11 November 2021
  15. Identification of novel single nucleotide variants in the drug resistance mechanism of Mycobacterium tuberculosis isolates by whole-genome analysis

    Background

    Tuberculosis (TB) represents a major global health challenge. Drug resistance in Mycobacterium tuberculosis (MTB) poses a substantial...

    Weiye Qian, Nan Ma, ... Stephen Kwok-Wing Tsui in BMC Genomics
    Article Open access 14 May 2024
  16. Co-production of metallo-β-lactamase and OXA-type β-lactamases in carbapenem-resistant Acinetobacter baumannii clinical isolates in North East India

    Carbapenem-resistant Acinetobacter baumannii poses a significant threat to public health globally, especially due to its ability to produce multiple...

    Shyamalima Saikia, Indrani Gogoi, ... Pankaj Chetia in World Journal of Microbiology and Biotechnology
    Article 17 April 2024
  17. The Impact of Fosfomycin on Gram Negative Infections: A Comprehensive Review

    Multidrug-resistant or extended drug resistance has created havoc when it comes to patient treatment, as options are limited because of the spread of...

    Sandeepika Dubey, Areena Hoda Siddiqui, Meenakshi Sharma in Indian Journal of Microbiology
    Article 07 May 2024
  18. In vitro and ex vivo activity of the fluoroquinolone DC-159a against mycobacteria

    Antimicrobial resistance is a global health problem. In 2021, it was estimated almost half a million of multidrug-resistant tuberculosis (MDR-TB)...

    Belén R. Imperiale, María B. Mancino, ... Nora S. Morcillo in The Journal of Antibiotics
    Article 04 March 2024
  19. The Role of Advanced Therapeutic Techniques to Combat Multi-drug Resistance

    A wide variety of microbial pathogens use distinct mechanisms to evade selection pressure and subsequently develop drug resistance towards...
    Musa Marimani, Aijaz Ahmad, Adriano Duse in Non-traditional Approaches to Combat Antimicrobial Drug Resistance
    Chapter 2023
  20. Whole genome sequencing reveals candidate genes involving in PAS resistance in M. Tuberculosis isolated from patients in Thailand

    Para-amino salicylic acid (PAS) was first reported by Lehmann in 1946 and used for tuberculosis treatment. However, due to its adverse effects, it is...

    Kanchana Dokladda, Pamaree Billamas, ... Therdsak Prammananan in World Journal of Microbiology and Biotechnology
    Article 07 December 2023
Did you find what you were looking for? Share feedback.